Correlation of baseline 18F-FDG-PET/CT parameters with the outcome of advanced melanoma patients treated with the pd-1 blocking monoclonal antibody pembrolizumab
- Gondry, O. (Speaker)
- Özdemir, I. (Contributor)
- Yanina Jansen (Contributor)
- Awada, G. (Contributor)
- Schwarze, J. K. (Contributor)
- Teofila Seremet (Contributor)
- Everaert, H. (Contributor)
- Neyns, B. (Contributor)
- Keyaerts, M. (Contributor)
Activiteit: Talk or presentation at a workshop/seminar